MiR-30a-5p confers cisplatin resistance by regulating IGF1R expression in melanoma cells

BACKGROUND: Melanoma is notoriously resistant to all current modalities of cancer therapies including chemotherapy. In recent years, microRNAs (miRNAs) have emerged as molecular regulators in the development and progression of melanoma. However, the relationship between microRNA and chemo-resistance...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yuxia, Zhang, Jie, Liu, Yajing, Zhang, Bingyue, Zhong, Fubo, Wang, Shubin, Fang, Zhengyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896053/
https://www.ncbi.nlm.nih.gov/pubmed/29642855
http://dx.doi.org/10.1186/s12885-018-4233-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896053/
https://www.ncbi.nlm.nih.gov/pubmed/29642855
http://dx.doi.org/10.1186/s12885-018-4233-9

Ejemplares similares